Exelixis Inc (NAS:EXEL)
$ 36.04 0.19 (0.53%) Market Cap: 10.29 Bil Enterprise Value: 9.22 Bil PE Ratio: 23.10 PB Ratio: 4.53 GF Score: 91/100

Exelixis Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2021 / 10:20PM GMT
Release Date Price: $24.15 (+5.83%)
Unidentified Analyst

Good afternoon, everyone. My name is [Ray Wang], and I am a member of the JPMorgan Healthcare Investment Banking team. Thank you all for joining the session today. (Operator Instructions) With that, it is my pleasure to introduce Mike Morrissey, President and CEO of Exelixis.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

All right. Ray, thank you very much, and welcome, everybody. Thanks for joining us this afternoon. I hope everybody is having a good start to 2021, and a good first day at the JPMorgan conference. I am really excited to be able to take some time today and share with you our updates and plans for how we are building a leading multi-product oncology company at Exelixis. We had a very busy successful year in 2020 and super excited about where we're going in 2021.

So I've got slides in front of me. I understand that you all have the ability to advanced slides on year-end individually. So what I'll be doing today is simply calling out what slide I'm on. And the numbers are on the bottom right-hand

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot